Truliant Porous Knee System Launches Reports Exactech

Truliant Porous Knee System Full Launch

Exactech, a developer and producer of innovative implants, instrumentation and smart technologies for joint replacement surgery, today announced the expansion of its Truliant® Total Knee System with a new porous-coated implant option.

Full launch of the Truliant Porous Knee System is welcome news for surgeons who are interested in a non-cemented approach. It enhances the award-winning knee system and is designed for strength and stability for patients, and efficiency for surgeons and staff in the operating room.

“Exactech’s Truliant Porous Knee system embodies state-of-the-art technology, manufacturing and instrumentation allowing surgeons to confidently address our ever-changing patient populations,” said James B. Duke, MD, of the Orthopaedic Institute in Ocala, Fla. “I believe surgeons looking to maximize longevity, performance and durability in their implants will want to utilize Exactech’s Truliant Porous Knee technology to best handle surgical challenges and patient expectations.”

The Truliant Porous Knee enhances the company’s advanced material science platform with a solution that is designed to mimic the trabecular nature of cancellous bone with optimal pore size and porosity. The porous structures integrated into the implant design are designed to facilitate a durable bonding surface to allow for immediate and long-term biological fixation. Peripheral pegs allow for stable initial fixation while the channeled keel is designed with flutes to increase bony-implant engagement for increased stability and resistance to micromotion.

The Truliant Porous Knee seamlessly integrates with the system’s ergonomically designed mechanical instrumentation and the ExactechGPS® TKA Pro application for a guided, personalized experience. The Truliant Total Knee System includes cruciate-retaining and posterior-stabilized implants, as well as constrained insert options, and integrates with a fully comprehensive revision system that offers metaphyseal cones, stems, tibial augments and offsets.

SourceExactech
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Led by researchers at NYU Grossman School of Medicine, the study results add to evidence that neighboring brain regions, the inferior frontal gyrus and the motor cortex, play an important role in such planning before words are said aloud. Both are part of the folded top layers of the brain, or cerebral cortex, which has long been known to control the muscle (motor) movements in the throat and mouth needed to produce speech. Less clear until now was how closely these regions determine the mix of sounds and words people want to say aloud, the authors report.
PolarisAR describes STELLAR Knee as a mixed-reality surgical navigation platform that guides TKA procedures by displaying measured and computed data overlaid directly in a 3D environment. The mixed-reality system acts as a spatial computer, creating continuous data exchange between the surgeon and the software to help enhance surgical decision-making while simplifying operating room workflow.
This February, the first enrolled patient underwent open surgical aortic arch reconstruction at the University of Pennsylvania, Presbyterian Medical Center, Philadelphia, PA.  During the surgery, the Duett Vascular Graft System was successfully deployed to connect the native left common carotid artery to the surgical graft.
"Our ultra low insertion loss Athermal AWG Multiplexers along with temperature-hardened low-drift AAWG specifically designed for the industrial temperature applications will be marketed aggressively through partnership companies in the East Asia and EU regions after its success in the North America," says Dr. Donald Yu, CMO of POINTek, who runs global marketing operations from Los Angeles, California.
AUX-001 is an innovative, once-daily, extended-release formulation of Nicorandil. For decades, immediate-release, twice daily Nicorandil has been a cornerstone treatment for chronic angina symptoms outside the US, distinguished by its dual mechanism of action that targets both the micro- and macrovascular coronary artery flow bed, and providing sustained angina symptom relief without the common issue of tachyphylaxis seen with other anti-anginal vasodilators like long-acting nitrates. AUX-001 offers efficacy comparable to conventional anti-anginal medications such as beta-blockers, calcium channel blockers, and long-acting nitrates while also potentially enhancing control of the underlying coronary disease and reducing angina related hospitalizations.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version